← 返回列表 SCI 期刊 医学 N-S ARCH PHARMACOL

Naunyn-Schmiedebergs Archives of Pharmacology

N-S ARCH PHARMACOL

Print ISSN 0028-1298 Online ISSN 1432-1912
SCIE Q2 新锐3区 传统4区 混合OA 医学
影响因子 2026
4
↑ 0.9
5年均分
3.1
5-Year IF
H 指数
83
H-Index
年发文量
112
Articles / Year
出刊频率
Monthly
Pub. Frequency
创刊年份
1873
Founded Year
出版商
Springer
Publisher
出版国家
Germany
Country
投稿参考 & 用户评分
🏆 期刊声誉
暂无
综合口碑评分,点击星星参与
审稿速度
系统
暂无
1.8 个月
💰 版面费用
系统
暂无
官方APC $4,390 USD 约¥31,828
中科院分区
2026新锐分区 新体系
大类3区
医学Medicine
小类3区
药学Pharmacology & Pharmacy
中科院2025年分区 传统体系
大类4区
医学Medicine
小类4区
药学Pharmacology & Pharmacy
WoS 期刊 JCR 分区 (2026 · JIF) 综合 SCIE Q2
学科 收录集 JIF 分区 JIF 排名 JIF 百分位
药学与药理学 Pharmacology & Pharmacy SCIE Q2 109/356
69.4%
按 JCI 指标学科分区
学科 收录集 JCI 分区 JCI 排名 JCI 百分位
药学与药理学 Pharmacology & Pharmacy SCIE Q2 90/319 JCI 0.90
72.1%
Scopus 指标
CiteScore
4.4
综合引用得分
SJR
0.877 Q2
SCImago Journal Rank
SNIP
1.020
Source Normalized Impact
JCI
0.90
Journal Citation Indicator
数据来源:Scopus (CiteScore · SJR · SNIP) · Clarivate (JCI)。指标年份:2026年6月最新版。
期刊简介

Naunyn-Schmiedeberg's Archives of Pharmacology is a distinguished international journal published by Springer, dedicated to the broad field of experimental and clinical pharmacology. With a 2026 Impact Factor of 4.000 and a JCR Quartile ranking of Q2, the journal holds a strong, established position within the pharmacological sciences, serving as a vital resource for researchers and clinicians alike. The journal’s scope encompasses the full spectrum of pharmacological investigation, including molecular pharmacology, receptor pharmacology, drug metabolism and toxicology, neuropharmacology, cardiovascular pharmacology, and preclinical drug development. It places particular emphasis on studies elucidating mechanisms of drug action, pharmacokinetics, and the therapeutic potential of novel compounds. Naunyn-Schmiedeberg's Archives primarily publishes original research articles, but also features authoritative review articles, rapid communications, and occasional special issues focused on emerging topics or conference proceedings. The target audience includes academic researchers, pharmacologists, toxicologists, pharmaceutical scientists, and medical professionals seeking rigorous, peer-reviewed insights into drug action. A notable feature is its open access option, allowing authors to make their work freely available to a global audience, thereby increasing visibility and impact. The journal is indexed in all major databases, including MEDLINE, Scopus, and Web of Science. As a Q2 title with a solid impact factor, it is recognized as a reputable and reliable venue for high-quality pharmacological research, bridging fundamental science and clinical application.

历年影响因子 & 年发文量

上述信息均来源于网络,以官方发布为准,仅供参考。如有建议,欢迎反馈

生物行 © 2002–2026  All Rights Reserved.